What is ADME Suite?
Forecasting the absorption, distribution, metabolism, and excretion (ADME) characteristics based on chemical structure is crucial. This set of precise calculations pertaining to pharmacokinetic properties is beneficial for facilitating high-throughput screening of various libraries. Additionally, it offers valuable insights into pharmacological impacts, aiding in the assurance of human safety for the products being developed. Such predictive modeling can significantly enhance the efficiency of drug discovery processes.
Integrations
No integrations listed.
Similar Software to ADME Suite
Castor EDC
Castor is an innovative clinical trial platform designed to simplify data management through electronic data capture (EDC), eConsent, and patient-reported outcomes (ePRO). Its flexible and user-friendly interface allows researchers to collect, manage, and analyze clinical data efficiently across multiple sites and remote patients. Castor’s tools are specifically designed to support decentralized clinical trials (DCTs), enabling real-time data monitoring, remote recruitment, and seamless patient engagement. The platform ensures full regulatory compliance, including HIPAA, GDPR, and 21 CFR Part 11, and is certified for ISO standards. With more than 50,000 global users, Castor continues to improve the speed and quality of clinical trials through integrated, scalable solutions that reduce administrative burdens and accelerate research.
Learn more
QUALO
QUALO is a versatile cloud-based software solution aimed at addressing significant challenges related to data output and visualization within behavioral health, community health, and healthcare sectors. Its main objective is to provide meaningful insights while ensuring that clients, staff, administrators, and funders are not inundated with excessive information.
The platform merges data collection capabilities with tailored evidence-based practice supports, allowing for the accurate gathering of relevant data precisely when needed. Furthermore, it features specialized care coordination tools specifically designed to meet the unique needs of human service providers.
A major advantage of QUALO is its ability to integrate smoothly with various systems, particularly electronic health records (EHRs). By serving as a centralized data entry hub, it aims to mitigate the common shortcomings found in the data output and visualization of EHRs. In addition, QUALO's mobile-optimized interface facilitates access from a variety of devices, thus improving the overall efficiency of the data collection workflow. This adaptability ensures that users can engage with the platform whenever and wherever they need to make informed decisions.
Learn more
Absolv
Determine the Abraham Solvation Parameters along with various solvation-related characteristics for solutes based solely on their chemical structures. This approach allows for a deeper understanding of solute behaviors in different solvent environments.
Learn more
Iktos
Makya emerges as a groundbreaking user-focused SaaS platform specifically tailored for AI-driven de novo drug design, with a particular focus on Multi-Parametric Optimization (MPO). This cutting-edge tool enables users to generate original and easily synthesizable compounds through a multi-objective framework, achieving unparalleled speed, efficiency, and diversity in results. Featuring a variety of generative algorithms that cater to different phases of drug development—from hit discovery to lead optimization—Makya includes a fine-tuning generator for identifying optimal solutions within your defined chemical space, a novelty generator aimed at uncovering new ideas for re-scaffolding and hit identification, and a forward generator that assembles a specialized library of compounds ready for synthesis using commercially accessible starting materials. The platform's latest addition, the Makya 3D module, markedly enhances both the user experience and scientific functionality. With an extensive toolkit of 3D modeling capabilities for both ligand-based and structure-based methodologies, Makya 3D facilitates the computation of 3D scores that can be effortlessly integrated to steer compound generation within the platform. This comprehensive integration not only refines the design workflow but also provides researchers with profound insights into their molecular architectures, ultimately transforming the drug discovery landscape. As researchers increasingly seek innovative solutions, Makya stands at the forefront, revolutionizing the way compounds are designed and developed.
Learn more
Screenshots and Video
Company Facts
Company Name:
ACD/Labs
Date Founded:
1994
Company Location:
Canada
Company Website:
www.acdlabs.com/products/percepta-platform/adme-suite/
Product Details
Deployment
Windows
Product Details
Target Company Sizes
Individual
1-10
11-50
51-200
201-500
501-1000
1001-5000
5001-10000
10001+
Target Organization Types
Mid Size Business
Small Business
Enterprise
Freelance
Nonprofit
Government
Startup
Supported Languages
English